Association of TLR8 Variants in Sex-Based Clinical Differences in Patients with COVID-19.

Publication date: Jun 01, 2025

The host immune response might confer differential vulnerability to SARS-CoV-2 infection. The Toll-like receptor 8 (TLR8), could participated for severe COVID-19 outcomes. To investigated the relationship of TLR8 rs3764879-C/G, rs3764880-A/G, and rs3761624-A/G with COVID-19 outcomes and with biochemical parameters. A cross-sectional study of 830 laboratory-confirmed COVID-19 patients was performed, and classified into mild, severe, critical, and deceased outcomes. The TLR8 rs3764879-C/G, rs3764880-A/G, and rs3761624-A/G polymorphisms were genotyped. A logistic regression analysis was performed to determinate the association with COVID-19. A stratified analysis was by alleles was done with clinical and metabolic markets. In all outcomes, men presented the highest ferritin levels compared to women (P 

Concepts Keywords
Covid Adult
Immune Aged
Laboratory C-Reactive Protein
Rs3764879 C-Reactive Protein
Women Clinical features
COVID-19
COVID-19
Cross-Sectional Studies
Female
Ferritins
Ferritins
Haplotypes
Humans
Male
Middle Aged
POLYMORPHISM
Polymorphism, Single Nucleotide
SARS-CoV-2
Sex Factors
TLR8
TLR8 protein, human
Toll-Like Receptor 8
Toll-Like Receptor 8

Semantics

Type Source Name
disease MESH COVID-19
disease IDO host
disease IDO immune response
pathway REACTOME SARS-CoV-2 Infection

Original Article

(Visited 2 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *